- Home
- ZLAB vs NOG Comparison
ZLAB vs NOG Comparison
Compare ZLAB & NOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ZLAB | NOG |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.6B |
| IPO Year | 2017 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ZLAB | NOG |
|---|---|---|
| Price | $18.57 | $21.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $49.60 | $31.14 |
| AVG Volume (30 Days) | 640.0K | ★ 2.5M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 6.44% |
| EPS Growth | ★ 38.46 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $460,156,000.00 | ★ $2,475,723,000.00 |
| Revenue This Year | $9.75 | $14.07 |
| Revenue Next Year | $26.03 | $4.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.33 | 11.23 |
| 52 Week Low | $15.96 | $20.18 |
| 52 Week High | $44.34 | $32.62 |
Technical Indicators
Market Signals| Indicator | ZLAB | NOG |
|---|---|---|
| Relative Strength Index (RSI) | 41.21 | 30.92 |
| Support Level | $16.88 | $21.41 |
| Resistance Level | $19.64 | $22.86 |
| Average True Range (ATR) | 0.87 | 0.77 |
| MACD | -0.14 | -0.22 |
| Stochastic Oscillator | 22.67 | 9.29 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
About NOG Northern Oil and Gas Inc.
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).